Explore the Journal of Drugs in Dermatology (JDD), a monthly peer-reviewed, PubMed® indexed dermatology journal & online resource.
Complimentary subscriptions for US dermatologists, dermatology residents, nurse practitioners and physician assistants.
From JDD's Vault: The State of Sunscreens in the US: Caveat Emptor With the FDA’s groundbreaking June 2026 approval of a new sunscreen ingredient, bemotrizinol (also called BEMT or Tinosorb…
Beyond the Skin: Navigating Psoriasis Treatment and Patient Burden Management of psoriasis can often involve trialing several medications, extensive patient counseling, and working with insurance companies to get the optimal…
New Data on Acne Linked to Oral JAK Inhibitors: What Dermatology Clinicians Should Know Have you read this article from the JDD? Acne is emerging as a notable cutaneous adverse…
Rapid Itch Relief in Eczema: New JDD Data on Moisturizer and Cream Performance This is a must-read article from JDD for dermatologists and dermatology healthcare professionals following the day-to-day management…
Rapid Clearance Metrics: Evaluating Early Biologic Efficacy in Moderate-to-Severe Plaque Psoriasis This is a must-read article from the JDD for any clinician managing moderate-to-severe plaque psoriasis in daily practice. As…
Rethinking Pigmented Basal Cell Carcinoma in Skin of Color Have you had a chance to look over this latest publication from the Journal of Drugs in Dermatology? A new systematic…